Scholarlink

<p>Carbapenem-resistant Enterobacterales (CRE) constitute an urgent global health threat, and microbiota-based strategies are increasingly being sought as alternatives to conventional antibiotics. To identify a probiotic candidate with potent anti-CRE activity, we isolated human-derived <i>Lactiplantibacillus plantarum</i> LP1 and performed integrated phenotypic and genomic analyses. <i>L. plantarum</i> LP1 displayed outstanding gastrointestinal tolerance (relative survival/proliferation rate of 113.22%) and high adhesion to Caco-2 cells (99.01%), outperforming the reference strain <i>L. plantarum</i> ATCC 14917, while cell-free supernatants completely inhibited CRE growth and removed up to 82.31 ± 2.24% of preformed biofilms. Hybrid whole-genome sequencing produced a complete 3.31&#xa0;Mb circular chromosome assembled as a single contig, comprising 3,109 coding sequences and more than 500 genes absent from the reference strain <i>L. plantarum</i> ATCC 14917, including 2,977 clusters of orthologous groups (COG)-classified genes (216 related to carbohydrate transport and metabolism) and 53 carbohydrate-active enzymes, consistent with the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment of carbohydrate metabolic pathways. BAGEL4 analysis identified a class IIb plantaricin gene cluster, supporting a bacteriocin-mediated mechanism of CRE inhibition. Collectively, these findings demonstrate that <i>L. plantarum</i> LP1 possesses strain-specific expansion of metabolic and antimicrobial functions that underpin its strong anti-CRE activity and highlight its potential as a next-generation probiotic.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Functional and Genomic Characterization of a Human-Derived Lactiplantibacillus plantarum Strain LP1 with Activity Against Carbapenem-Resistant Enterobacterales

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Hyeon-Jin Kim,
  • Hyeonah Lee,
  • Songhee Lee,
  • Sanghee Park,
  • Jung Wook Kim

摘要

Carbapenem-resistant Enterobacterales (CRE) constitute an urgent global health threat, and microbiota-based strategies are increasingly being sought as alternatives to conventional antibiotics. To identify a probiotic candidate with potent anti-CRE activity, we isolated human-derived Lactiplantibacillus plantarum LP1 and performed integrated phenotypic and genomic analyses. L. plantarum LP1 displayed outstanding gastrointestinal tolerance (relative survival/proliferation rate of 113.22%) and high adhesion to Caco-2 cells (99.01%), outperforming the reference strain L. plantarum ATCC 14917, while cell-free supernatants completely inhibited CRE growth and removed up to 82.31 ± 2.24% of preformed biofilms. Hybrid whole-genome sequencing produced a complete 3.31 Mb circular chromosome assembled as a single contig, comprising 3,109 coding sequences and more than 500 genes absent from the reference strain L. plantarum ATCC 14917, including 2,977 clusters of orthologous groups (COG)-classified genes (216 related to carbohydrate transport and metabolism) and 53 carbohydrate-active enzymes, consistent with the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment of carbohydrate metabolic pathways. BAGEL4 analysis identified a class IIb plantaricin gene cluster, supporting a bacteriocin-mediated mechanism of CRE inhibition. Collectively, these findings demonstrate that L. plantarum LP1 possesses strain-specific expansion of metabolic and antimicrobial functions that underpin its strong anti-CRE activity and highlight its potential as a next-generation probiotic.